Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for QGEN on February 6, 2026 10:39AM ET. The previous analyst recommendation was Overweight.QGEN was trading at $51.23 at issue of the analyst...

February 6, 2026   QGEN -4.40%

Barclays analyst issues OVERWEIGHT recommendation for SUNC on February 6, 2026 10:43AM ET. The previous analyst recommendation was Overweight.SUNC was trading at $54.1 at issue of the analyst...

February 6, 2026   SUNC -0.22%

Barclays analyst issues OVERWEIGHT recommendation for SUN on February 6, 2026 10:42AM ET. The previous analyst recommendation was Overweight.SUN was trading at $58.32 at issue of the analyst...

February 6, 2026   SUN -0.28%

Citigroup analyst issues OUTPERFORM recommendation for RBBN on February 6, 2026 10:51AM ET. The previous analyst recommendation was Outperform.RBBN was trading at $2.72 at issue of the analyst...

February 6, 2026   RBBN 0.07%

Citigroup analyst issues OUTPERFORM recommendation for TRNO on February 6, 2026 10:52AM ET. The previous analyst recommendation was Outperform.TRNO was trading at $65.08 at issue of the analyst...

February 6, 2026   TRNO -0.92%

Citigroup analyst issues NEUTRAL recommendation for SLAB on February 6, 2026 10:53AM ET. The previous analyst recommendation was Neutral.SLAB was trading at $205.22 at issue of the analyst...

February 6, 2026   SLAB -0.49%

Barclays analyst issues OVERWEIGHT recommendation for UNM on February 6, 2026 10:44AM ET. The previous analyst recommendation was Overweight.UNM was trading at $75.66 at issue of the analyst...

February 6, 2026   UNM -0.21%

Citigroup analyst issues BUY recommendation for XPEV on February 6, 2026 10:52AM ET. The previous analyst recommendation was Buy.XPEV was trading at $16.88 at issue of the analyst...

February 6, 2026   XPEV 2.17%

Barclays analyst issues OVERWEIGHT recommendation for XPO on February 6, 2026 10:45AM ET. The previous analyst recommendation was Overweight.XPO was trading at $185.62 at issue of the analyst...

February 6, 2026   XPO -0.42%

Barclays analyst issues OVERWEIGHT recommendation for ZBRA on February 6, 2026 10:45AM ET. The previous analyst recommendation was Overweight.ZBRA was trading at $241.08 at issue of the analyst...

February 6, 2026   ZBRA 0.56%